Nobuo Shiode Selected Research

Nobuo Shiode Research Topics

Disease

13	Myocardial Infarction 01/2023 - 01/2008
12	Thrombosis (Thrombus) 01/2021 - 02/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2008
4	Death (Near-Death Experience) 01/2023 - 06/2015
4	Hemorrhage 01/2021 - 01/2017
4	Diabetes Mellitus 04/2016 - 01/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 04/2015 - 07/2013
3	Pathologic Constriction (Stenosis) 09/2019 - 10/2009
3	Acute Coronary Syndrome 02/2015 - 12/2010
2	Atrial Fibrillation 10/2023 - 01/2022
2	Heart Failure 01/2023 - 02/2015
2	Coronary Disease (Coronary Heart Disease) 09/2022 - 01/2017
2	ST Elevation Myocardial Infarction 01/2022 - 04/2018
2	Cardiogenic Shock 01/2022 - 04/2018
2	Ischemic Stroke 01/2021 - 12/2020
1	Hypertension (High Blood Pressure) 01/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 09/2022
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Brugada Syndrome 01/2020
1	Syncope (Fainting) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Ventricular Fibrillation 01/2020
1	Pericardial Effusion 09/2019
1	Constrictive Pericarditis 09/2019
1	Ventricular Tachycardia 01/2017
1	Hyperemia 01/2017
1	Hematoma 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2015
1	Leriche Syndrome 01/2015
1	Renal Insufficiency (Renal Failure) 09/2014
1	Neoplasms (Cancer) 10/2013
1	Necrosis 06/2013
1	Chest Pain (Chest Pains) 06/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2012
1	Patent Ductus Arteriosus 09/2011
1	Unstable Angina 12/2010
1	Hyperplasia 10/2009
1	Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia) 04/2003
1	Tachycardia (Tachyarrhythmias) 04/2003

Drug/Important Bio-Agent (IBA)

9	Sirolimus (Rapamycin)FDA Link 11/2015 - 02/2009
6	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2008
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 02/2009
3	MetalsIBA 01/2022 - 01/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2015 - 09/2014
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 12/2020
2	PapaverineIBA 01/2017 - 01/2017
2	thienopyridineIBA 11/2015 - 02/2009
2	BESIBA 10/2015 - 07/2013
1	Lipoprotein(a)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	Dextrans (Dextran)FDA Link 09/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Methicillin (Metin)FDA Link 09/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2018
1	Contrast MediaIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2015
1	Fatty Acid Binding Protein 3IBA 06/2013
1	Biomarkers (Surrogate Marker)IBA 06/2013
1	Fatty Acid-Binding ProteinsIBA 06/2013
1	TroponinIBA 06/2013
1	Proteoglycans (Proteoglycan)IBA 10/2009

Therapy/Procedure

20	Stents 01/2022 - 02/2009
10	Therapeutics 01/2022 - 04/2003
9	Drug-Eluting Stents 01/2022 - 02/2009
6	Percutaneous Coronary Intervention 01/2022 - 01/2008
2	Catheter Ablation 10/2023 - 04/2003
1	Treatment Delay 01/2022
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Intravenous Administration 09/2019
1	Punctures 01/2017
1	Catheters 01/2017
1	Drug Therapy (Chemotherapy) 10/2013
1	Aftercare (After-Treatment) 07/2013
1	Renal Dialysis (Hemodialysis) 01/2012
1	Ligation 09/2011
1	Radiofrequency Ablation 04/2003